Might 8, 2024 – Andrew Baum, MD, joins Pfizer as Chief Technique and Innovation Officer and Govt Vice President. Dr. Baum will function a member of Pfizer's Govt Management Workforce and report back to Chairman and Chief Govt Officer, Dr. Albert Bourla. Dr. Baum joins Pfizer from Citi, the place he was Head of International Healthcare and Managing Director of Fairness Analysis.

Earlier than becoming a member of Citi in 2011, Dr. Baum was liable for European pharmaceutical merchandise at Morgan Stanley for fourteen years. Earlier in his profession he was a practising doctor on the Royal Nationwide Orthopedic Radcliffe Hospital in Oxford, the place he accomplished his residency.

At Pfizer, Dr. Baum will play a important function in advancing Pfizer's long-term strategic plan to maximise worth for sufferers and shareholders. He may also be liable for the corporate's portfolio evaluation and prioritization features, enterprise improvement actions, strengthening partnerships with the biotech ecosystem and industrial analysis of our analysis pipeline.

Dr. Baum will start his function at Pfizer on June 3, 2024, succeeding Aamir Malik, who lately moved to a brand new function at Pfizer as Chief US Business Officer and Govt Vice President.

Study extra